• Home
  • Contact Us
  • Sitemap
  • About Aveo
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Product Candidates
    • Overview
    • Tivozanib (AV-951)
    • Ficlatuzumab (AV-299)
    • AV-203
    • For Physicians
    • For Patients
  • Discovery Programs
    • Overview
    • FGF Program
    • Notch Program
    • RON Program
  • Our Platform
    • Platform Overview
  • Partnering
    • Our Approach
    • Our Partners
    • Areas of Interest
  • Partnering
     
    • About Aveo
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Careers
        • Overview
        • Testimonials
        • Benefits
        • AVEO Voices
    • Product Candidates
      • Overview
      • Tivozanib (AV-951)
      • Ficlatuzumab (AV-299)
      • AV-203
      • For Physicians
      • For Patients
    • Discovery Programs
      • Overview
      • FGF Program
      • Notch Program
      • RON Program
    • Our Platform
      • Platform Overview
    • Partnering
      • Our Approach
      • Our Partners
      • Areas of Interest
    • Contact Us
    • Terms
     
     

    © 2010 AVEO Pharmaceuticals, Inc. All rights reserved.

    • Home
    • Contact Us
    • Sitemap
    • Terms
    • Privacy
    •   |  
    • Investors
    • Careers